Conceptual application of Lactobacillus spp. as vaccine delivery vehicle
Abstract
Lactobacillus spp. are gram positive bacilli that have been isolated from foods, beverages, gastrointestinal tract and vargina of human and animals. Many species have been verified to carry probiotic properties that can be used in human. Currently, they are of interest in using Lactobacillus spp. as antigen delivery vehicle for carrying the antigens derived from bacteria, viruses, fungi and protozoa for immunization. The factors affecting the immunization efficacy including antigen locations and quantity of produced antigens in lactobacilli cell. This shot review will inform the reader about the concept of the development of Lactobacillus spp. as antigen delivery vector as alternative strategies for oral vaccine development in the near future.
References
1. Russell-Jones GJ. Oral vaccine delivery. J Control Release. 2000 Mar 1;65(1-2):49-54.
2. Fletcher HA. Sleeping Beauty and the Story of the Bacille Calmette-Guerin Vaccine. MBio. 2016 Aug 30;7(4).
3. มารุตพงศ์ ปัญญา. แลคโตบาซิลลัส: พื้นฐานสู่การประยุกต์ใช้ทางการแพทย์: สำนักพิมพ์มหาวิทยาลัยเกษตรศาสตร์; 2562.
4. Lebeer S, Vanderleyden J, De Keersmaecker SC. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev. 2008 Dec; 72(4):728-64, Table of Contents.
5. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 Apr;119(4):1019-21.
6. Lichtenstein L, Avni-Biron I, Ben-Bassat O. Probiotics and prebiotics in Crohn's disease therapies. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):81-8.
7. Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 2010 Aug 25; 10:253.
8. Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol. 1998 May; 84(5):759-68.
9. Panya M, Lulitanond V, Rattanachaikunsopon P, Srivoramas T, Chaiwong T. Isolation, Identification, and Evaluation of Novel Probiotic Strains Isolated from Feces of Breast-Fed Infants. J Med Assoc Thai. 2016 Jan;99 Suppl 1:S28-34.
10. Danielsen M, Wind A. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol. 2003 Jan 26;82(1):1-11.
11. Chen YL, Lee CC, Lin YL, Yin KM, Ho CL, Liu T. Obtaining long 16S rDNA sequences using multiple primers and its application on dioxin-containing samples. BMC Bioinformatics. 2015;16 Suppl 18:S13.
12. Kirtzalidou E, Pramateftaki P, Kotsou M, Kyriacou A. Screening for lactobacilli with probiotic properties in the infant gut microbiota. Anaerobe. 2011 Dec;17(6):440-3.
13. Moreira JL, Mota RM, Horta MF, Teixeira SM, Neumann E, Nicoli JR, et al. Identification to the species level of Lactobacillus isolated in probiotic prospecting studies of human, animal or food origin by 16S-23S rRNA restriction profiling. BMC Microbiol. 2005 Mar 23;5:15.
14. Ventura M, Casas IA, Morelli L, Callegari ML. Rapid amplified ribosomal DNA restriction analysis (ARDRA) identification of Lactobacillus spp. isolated from fecal and vaginal samples. Syst Appl Microbiol. 2000 Dec;23(4):504-9.
15. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol. 2002 Jan;9(1):92-6.
16. Roy D, Ward P, Vincent D, Mondou F. Molecular identification of potentially probiotic lactobacilli. Curr Microbiol. 2000 Jan; 40(1):40-6.
17. Sasikumar P, Gomathi S, Anbazhagan K, Abhishek A, Paul E, Vasudevan V, et al. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats. J Biomed Sci. 2014 Aug 30; 21:86.
18. Kajikawa A, Zhang L, LaVoy A, Bumgardner S, Klaenhammer TR, Dean GA. Mucosal Immunogenicity of Genetically Modified Lactobacillus acidophilus expressing an HIV-1 Epitope within the Surface Layer Protein. PLoS One. 2015;10(10):e0141713.
19. Geriletu, Xu R, Jia H, Terkawi MA, Xuan X, Zhang H. Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice. Curr Microbiol. 2011 May;62(5):1573-80.
20. Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol. 2005 Oct;68(6):705-17.
21. Eijsink VG, Axelsson L, Diep DB, Havarstein LS, Holo H, Nes IF. Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication. Antonie Van Leeuwenhoek. 2002 Aug;81(1-4):639-54.
22. Martin MC, Fernandez M, Martin-Alonso JM, Parra F, Boga JA, Alvarez MA. Nisin-controlled expression of Norwalk virus VP60 protein in Lactobacillus casei. FEMS Microbiol Lett. 2004 Aug 15;237(2):385-91.
23. Pavan S, Hols P, Delcour J, Geoffroy MC, Grangette C, Kleerebezem M, et al. Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: a tool to study in vivo biological effects. Appl Environ Microbiol. 2000 Oct;66(10):4427-32.
24. Xu Y, Li Y. Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein. Appl Environ Microbiol. 2007 Nov;73(21):7041-7.
25. Adachi K, Kawana K, Yokoyama T, Fujii T, Tomio A, Miura S, et al. Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7. Vaccine. 2010 Apr 1;28(16):2810-7.
26. Yoon SW, Lee TY, Kim SJ, Lee IH, Sung MH, Park JS, et al. Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice. Vaccine. 2012 May 9;30(22):3286-94.
27. Ho PS, Kwang J, Lee YK. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine. 2005 Feb 3;23(11):1335-42.
28. Okuno T, Kashige N, Satho T, Irie K, Hiramatsu Y, Sharmin T, et al. Expression and secretion of cholera toxin B subunit in lactobacilli. Biol Pharm Bull. 2013;36(6):952-8.
29. Kajikawa A, Satoh E, Leer RJ, Yamamoto S, Igimi S. Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine. 2007 May 4;25(18):3599-605.
30. Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, et al. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol. 2012 Sep;19(9):1374-81.
31. del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, et al. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol. 2008 Sep;15(9):1429-35.
32. Grangette C, Muller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun. 2001 Mar;69(3):1547-53.
33. Cortes-Perez NG, Azevedo V, Alcocer-Gonzalez JM, Rodriguez-Padilla C, Tamez-Guerra RS, Corthier G, et al. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J Drug Target. 2005 Feb;13(2):89-98.
34. Mayo MPB. Lactic acid bacteria: an alternative platform for live vaccine development. The Asia-Pacific Journal of Science and Technology. 2014;19(5):734-42.
35. Reveneau N, Geoffroy MC, Locht C, Chagnaud P, Mercenier A. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine. 2002 Mar 15;20(13-14):1769-77.
2. Fletcher HA. Sleeping Beauty and the Story of the Bacille Calmette-Guerin Vaccine. MBio. 2016 Aug 30;7(4).
3. มารุตพงศ์ ปัญญา. แลคโตบาซิลลัส: พื้นฐานสู่การประยุกต์ใช้ทางการแพทย์: สำนักพิมพ์มหาวิทยาลัยเกษตรศาสตร์; 2562.
4. Lebeer S, Vanderleyden J, De Keersmaecker SC. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev. 2008 Dec; 72(4):728-64, Table of Contents.
5. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 Apr;119(4):1019-21.
6. Lichtenstein L, Avni-Biron I, Ben-Bassat O. Probiotics and prebiotics in Crohn's disease therapies. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):81-8.
7. Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 2010 Aug 25; 10:253.
8. Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol. 1998 May; 84(5):759-68.
9. Panya M, Lulitanond V, Rattanachaikunsopon P, Srivoramas T, Chaiwong T. Isolation, Identification, and Evaluation of Novel Probiotic Strains Isolated from Feces of Breast-Fed Infants. J Med Assoc Thai. 2016 Jan;99 Suppl 1:S28-34.
10. Danielsen M, Wind A. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol. 2003 Jan 26;82(1):1-11.
11. Chen YL, Lee CC, Lin YL, Yin KM, Ho CL, Liu T. Obtaining long 16S rDNA sequences using multiple primers and its application on dioxin-containing samples. BMC Bioinformatics. 2015;16 Suppl 18:S13.
12. Kirtzalidou E, Pramateftaki P, Kotsou M, Kyriacou A. Screening for lactobacilli with probiotic properties in the infant gut microbiota. Anaerobe. 2011 Dec;17(6):440-3.
13. Moreira JL, Mota RM, Horta MF, Teixeira SM, Neumann E, Nicoli JR, et al. Identification to the species level of Lactobacillus isolated in probiotic prospecting studies of human, animal or food origin by 16S-23S rRNA restriction profiling. BMC Microbiol. 2005 Mar 23;5:15.
14. Ventura M, Casas IA, Morelli L, Callegari ML. Rapid amplified ribosomal DNA restriction analysis (ARDRA) identification of Lactobacillus spp. isolated from fecal and vaginal samples. Syst Appl Microbiol. 2000 Dec;23(4):504-9.
15. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol. 2002 Jan;9(1):92-6.
16. Roy D, Ward P, Vincent D, Mondou F. Molecular identification of potentially probiotic lactobacilli. Curr Microbiol. 2000 Jan; 40(1):40-6.
17. Sasikumar P, Gomathi S, Anbazhagan K, Abhishek A, Paul E, Vasudevan V, et al. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats. J Biomed Sci. 2014 Aug 30; 21:86.
18. Kajikawa A, Zhang L, LaVoy A, Bumgardner S, Klaenhammer TR, Dean GA. Mucosal Immunogenicity of Genetically Modified Lactobacillus acidophilus expressing an HIV-1 Epitope within the Surface Layer Protein. PLoS One. 2015;10(10):e0141713.
19. Geriletu, Xu R, Jia H, Terkawi MA, Xuan X, Zhang H. Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice. Curr Microbiol. 2011 May;62(5):1573-80.
20. Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol. 2005 Oct;68(6):705-17.
21. Eijsink VG, Axelsson L, Diep DB, Havarstein LS, Holo H, Nes IF. Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication. Antonie Van Leeuwenhoek. 2002 Aug;81(1-4):639-54.
22. Martin MC, Fernandez M, Martin-Alonso JM, Parra F, Boga JA, Alvarez MA. Nisin-controlled expression of Norwalk virus VP60 protein in Lactobacillus casei. FEMS Microbiol Lett. 2004 Aug 15;237(2):385-91.
23. Pavan S, Hols P, Delcour J, Geoffroy MC, Grangette C, Kleerebezem M, et al. Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: a tool to study in vivo biological effects. Appl Environ Microbiol. 2000 Oct;66(10):4427-32.
24. Xu Y, Li Y. Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein. Appl Environ Microbiol. 2007 Nov;73(21):7041-7.
25. Adachi K, Kawana K, Yokoyama T, Fujii T, Tomio A, Miura S, et al. Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7. Vaccine. 2010 Apr 1;28(16):2810-7.
26. Yoon SW, Lee TY, Kim SJ, Lee IH, Sung MH, Park JS, et al. Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice. Vaccine. 2012 May 9;30(22):3286-94.
27. Ho PS, Kwang J, Lee YK. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine. 2005 Feb 3;23(11):1335-42.
28. Okuno T, Kashige N, Satho T, Irie K, Hiramatsu Y, Sharmin T, et al. Expression and secretion of cholera toxin B subunit in lactobacilli. Biol Pharm Bull. 2013;36(6):952-8.
29. Kajikawa A, Satoh E, Leer RJ, Yamamoto S, Igimi S. Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine. 2007 May 4;25(18):3599-605.
30. Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, et al. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol. 2012 Sep;19(9):1374-81.
31. del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, et al. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol. 2008 Sep;15(9):1429-35.
32. Grangette C, Muller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun. 2001 Mar;69(3):1547-53.
33. Cortes-Perez NG, Azevedo V, Alcocer-Gonzalez JM, Rodriguez-Padilla C, Tamez-Guerra RS, Corthier G, et al. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J Drug Target. 2005 Feb;13(2):89-98.
34. Mayo MPB. Lactic acid bacteria: an alternative platform for live vaccine development. The Asia-Pacific Journal of Science and Technology. 2014;19(5):734-42.
35. Reveneau N, Geoffroy MC, Locht C, Chagnaud P, Mercenier A. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine. 2002 Mar 15;20(13-14):1769-77.
Downloads
Published
2019-04-30
How to Cite
ปัญญา ม. (2019). Conceptual application of Lactobacillus spp. as vaccine delivery vehicle. Journal of Medicine and Public Health, Ubon Ratchathani University, 2(1), 66–74. Retrieved from https://he01.tci-thaijo.org/index.php/jmpubu/article/view/195392
Issue
Section
Research Articles
License
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารการแพทย์และสาธารณสุข มหาวิทยาลัยอุบลราชธานี ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรง ซึ่งกองบรรณาธิการวารสารไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใด ๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารการแพทย์และสาธารณสุข มหาวิทยาลัยอุบลราชธานี ถือเป็นลิขสิทธิ์ของวารสารการแพทย์และสาธารณสุข มหาวิทยาลัยอุบลราชธานี กองบรรณาธิการไม่สงวนสิทธิ์ในการคัดลอกเพื่อการพัฒนางานด้านวิชาการ แต่ต้องได้รับการอ้างอิงที่ถูกต้องเหมาะสม
